With respect to medical heart failure treatment at hospital admission, patients with ischaemic HFrEF and prior MI were treated more often with ACE inhibitors/ARBs, beta-blockers, and mineralocorticoid receptor antagonists (MRAs) than were those without. Here, NR3C2 is linked to myocardial infarction.